Wendy is a Certified Bredesen Practitioner. She utilizes the Bredesen Protocol when working with dementia and cognitive decline.
The global burden of dementia is staggering, and unfortunately on the rise. Of the 318 million Americans currently living, 45 million will develop Alzheimer’s disease. There are 75 million Americans with ApoE4, the most important genetic risk factor for Alzheimer’s disease. It is expected that by 2050, there will be over 160,000,000 patients with Alzheimer’s disease globally. For women, Alzheimer’s is more common than breast cancer, as women make up over 65% of the patients and 60% of the caregivers. How can we improve this dire situation?
Dr. Dale Bredesen has spent over 30 years researching the treatment and prevention of Alzheimer’s disease, and has recently published the first paper on the Reversal Of Cognitive Decline in patients with early Alzheimer’s disease and its precursors, MCI and SCI.
THE BREDESEN PROTOCOL
The research performed by Dale Bredesen, MD, has opened the door to a new therapeutic approach for patients with Alzheimer disease. The Bredesen Protocol is a comprehensive lifestyle and nutrition approach to treating - and reversing - early-onset Alzheimer's, developed by Dr. Dale Bredesen, neurologist and researcher with the Buck Institute for Research on Aging. The Bredesen Protocol targets multiple underlying contributors to Alzheimer's disease. It’s an innovative protocol for reversing memory loss— and sustaining this improvement — using a complex, 36-point therapeutic program that involves comprehensive diet changes, brain stimulation, exercise, sleep optimization, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry."
Writing in the Journal of Aging, Bredesen details the successes in reversing the cognitive decline of early Alzheimer's disease. "Patients who had to discontinue work were able to return to work, and those struggling at work were able to improve their performance," writes Bredesen. "The patients, their spouses, and their co-workers all reported clear improvements."
In his 2016 paper, Dr. Bredesen offers up ten case studies of participants treated with the protocol for a period of time ranging anywhere from five months to two years. The results show unprecedented improvements in hippocampal volume and quantitative neuropsychological testing.
The case studies are compelling. Please refer to Dr. Bredesen’s website drbredesen.com for additional information on his research.
Contact Wendy if you would like to apply Dr. Bredesen’s research to your life. She is a Certified Bredesen Practitioner and would love to help you through the protocol.